• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓扑异构酶-I抑制剂CPT-11对新鲜分离的人胃癌和结直肠癌的体外抗肿瘤作用。

In vitro antitumor effect of topoisomerase-I inhibitor, CPT-11, on freshly isolated human gastric and colorectal cancer.

作者信息

Tsunoda T, Tanimura H, Hotta T, Tani M, Iwahashi M, Tanaka H, Matsuda K, Yamaue H

机构信息

Second Department of Surgery, Wakayama Medical School, Japan.

出版信息

Anticancer Res. 1999 Nov-Dec;19(6B):5451-5.

PMID:10697576
Abstract

CPT-11 is a comptothecin analogue which has shown a broad spectrum of strong antitumor effect against various cancers, including gastroenterological malignancies. In the present study, the antitumor effect of CPT-11 was determined by MTT assay for freshly isolated human gastric and colorectal cancer cells, especially highly purified tumor cells. Twenty-three patients with gastric cancer, and 32 patients with colorectal cancer were enrolled in this study. Three gastric and 3 colonic cancer cell lines were used to study the antitumor effect of CPT-11, and freshly isolated cancer cells from 3 patients with gastric cancer were investigated. The in vitro antitumor effect was tested by MTT assay, and showed % inhibition rate. CPT-11 and SN-38 showed the antitumor effect as a dose dependent matter for human gastric and colorectal tumor cells in vitro. From the results of chemosensitivity for freshly isolated gastric and colorectal tumor cells, antitumor effect of SN-38 was as strong as other conventional anticancer agents. It was demonstrated that the MTT assay was appropriate for the analysis of the antitumor effects of CPT-11 and SN-38, and that CPT-11 may be a worthwhile choice as an anticancer agent against gastric and colorectal cancer.

摘要

喜树碱-11(CPT-11)是一种喜树碱类似物,已显示出对包括胃肠道恶性肿瘤在内的各种癌症具有广泛的强效抗肿瘤作用。在本研究中,通过MTT法对新鲜分离的人胃癌和结肠癌细胞,尤其是高度纯化的肿瘤细胞,测定CPT-11的抗肿瘤作用。本研究纳入了23例胃癌患者和32例结肠癌患者。使用3种胃癌和3种结肠癌细胞系研究CPT-11的抗肿瘤作用,并对3例胃癌患者新鲜分离的癌细胞进行了研究。通过MTT法测试体外抗肿瘤作用,并显示出抑制率百分比。CPT-11和SN-38在体外对人胃癌和结肠肿瘤细胞显示出剂量依赖性的抗肿瘤作用。从新鲜分离的胃癌和结肠肿瘤细胞的化疗敏感性结果来看,SN-38的抗肿瘤作用与其他传统抗癌药物一样强。结果表明,MTT法适用于分析CPT-11和SN-38的抗肿瘤作用,并且CPT-11可能是作为抗胃癌和结肠癌的抗癌药物的一个值得选择的药物。

相似文献

1
In vitro antitumor effect of topoisomerase-I inhibitor, CPT-11, on freshly isolated human gastric and colorectal cancer.拓扑异构酶-I抑制剂CPT-11对新鲜分离的人胃癌和结直肠癌的体外抗肿瘤作用。
Anticancer Res. 1999 Nov-Dec;19(6B):5451-5.
2
In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
J Surg Oncol. 2000 Jan;73(1):6-11. doi: 10.1002/(sici)1096-9098(200001)73:1<6::aid-jso3>3.0.co;2-q.
3
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.胸苷酸合成酶抑制剂BGC9331与拓扑异构酶I抑制剂SN-38联合应用对人结肠癌细胞和乳腺癌细胞抗癌活性的增强作用:通过半胱天冬酶-3依赖和非依赖机制诱导细胞凋亡及ROCK裂解
Int J Oncol. 2005 Aug;27(2):553-61.
4
[Antitumor effect of SN-38, active form of CPT-11, on human colorectal cancer cell line].[CPT-11的活性形式SN-38对人结肠癌细胞系的抗肿瘤作用]
Gan To Kagaku Ryoho. 1994 Aug;21(10):1601-6.
5
Topoisomerase I inhibitors in the treatment of colorectal cancer.拓扑异构酶I抑制剂在结直肠癌治疗中的应用
Semin Oncol. 1999 Dec;26(6):632-9.
6
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.DNA拓扑异构酶I抑制剂SN-38与二氨基环己烷铂衍生物奥沙利铂联合应用的细胞药理学
Clin Cancer Res. 1999 May;5(5):1189-96.
7
A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo.一种新型水溶性喜树碱衍生物DX - 8951f在体外和体内对人类肿瘤均表现出强大的抗肿瘤活性。
Jpn J Cancer Res. 1995 Aug;86(8):776-82. doi: 10.1111/j.1349-7006.1995.tb02468.x.
8
Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units.
Anticancer Drugs. 1994 Apr;5(2):202-6. doi: 10.1097/00001813-199404000-00011.
9
Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.水溶性喜树碱衍生物DX-8951f对裸鼠体内多种人肿瘤异种移植瘤具有强效且广泛的抗肿瘤作用。
Cancer Chemother Pharmacol. 1998;42(3):210-20. doi: 10.1007/s002800050807.
10
Preclinical evaluation of CPT-11 and its active metabolite SN-38.CPT-11及其活性代谢产物SN-38的临床前评估。
Semin Oncol. 1996 Feb;23(1 Suppl 3):11-20.

引用本文的文献

1
Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.拓扑异构酶 I 而非胸苷酸合成酶与接受含伊立替康辅助化疗的结直肠癌患者的生存改善相关。
BMC Cancer. 2009 Sep 24;9:339. doi: 10.1186/1471-2407-9-339.